Physician profile
Robert A Wheeler
NPI 1659365740
$2,567.01
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $628 · 2021: $616 · 2022: $881.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $300.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $224.47 | 2019-2022 | |
| Novo Nordisk INC | $146.19 | 2019-2022 | |
| Abbvie INC. | $146.05 | 2021-2022 | |
| Indivior INC. | $138.56 | 2019-2022 | |
| Gilead Sciences, INC. | $135.87 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $124.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $102.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $101.76 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $95.84 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $95.37 | 2019 | |
| Pear Therapeutics (US), INC. | $93.68 | 2021-2022 | |
| Lilly USA, LLC | $89.39 | 2020-2022 | |
| Alkermes, INC. | $83.62 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $81.68 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $74.55 | 2022 | |
| Zealand Pharma US, INC. | $68.20 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $52.09 | 2021 | |
| Pfizer INC. | $49.69 | 2022 | |
| Astellas Pharma US INC | $42.94 | 2020-2021 | |
| Amgen INC. | $35.32 | 2019 | |
| Xeris Pharmaceuticals, INC. | $30.79 | 2021-2022 | |
| Daiichi Sankyo INC. | $30.57 | 2021-2022 | |
| Abbott Laboratories | $29.82 | 2019-2022 | |
| Valeritas, INC. | $27.55 | 2019 | |
| Ibsa Pharma INC. | $23.73 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.87 | 2022 | |
| Insulet Corporation | $18.07 | 2021 | |
| Esperion Therapeutics, INC. | $15.69 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.46 | 2021 | |
| Lifescan, INC. | $13.88 | 2020 | |
| Biogen, INC. | $13.13 | 2021 | |
| Amarin Pharma, INC. | $12.69 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.67 | 2022 | |
| Dexcom, INC. | $11.58 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.